drugset / Trial / NCT00624026
Memantine - Communication Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study objective is to evaluate the effects of memantine treatment on communication abilities and other cognitive abilities in moderate to severe DAT patients.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 20 mg | — |